Arena Pharmaceuticals Inc. (ARNA) is in the Pharma Industry

• Sort by
• View Related Content by Tag

• Arena Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator The question-and-answer session will be conducted electronically. Operator Instructions. Let's hear from Thomas Wei with Piper Jaffray. Thomas Wei - Piper Jaffray Hi. Thanks. I had a question on your comments about the look at the blinded data here on both efficacy and safety. So should we...

  Earnings calls 2008-08-05

  Tags: Arena Pharmaceuticals Inc.

• Arena Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Alan Carr with Needham. Please proceed. Alan Carr Hi good afternoon, everyone. Jack Lief Hi, Al. Alan Carr A couple of questions, one -- minor one I just wanted to get out of the way....

  Earnings calls 2008-05-07

  Tags: Arena Pharmaceuticals Inc.

• Arena Pharmaceuticals Q4 2007 Earnings Call Transcript

  Question-and-Answer Session Operator Operator Instructions. Question comes from the line of Cory Kasimov with JPMorgan. Please proceed. Unidentified Analyst Hey, guys. This is actually inaudible calling in for Cory. Thanks so much for taking my question. On the calls, you actually mentioned your sensitivity to the financing,...

  Earnings calls 2008-03-10

  Tags: Arena Pharmaceuticals Inc.

• Arena Pharmaceuticals Q3 2007 Earnings Call Transcript

  Question-and-Answer Session Operator Your first question comes from the line of Alan Carr with Needham.  Please proceed. Alan Carr - Needham & Company Hi, good afternoon.  Thanks for taking my question, and congratulations on a good quarter. Jack Lief Thank you. Alan Carr - Needham...

  Earnings calls 2007-10-17

  Tags: Arena Pharmaceuticals Inc.

Additional Resources

• Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference

  SAN DIEGO, Oct. 7 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the Natixis Bleichroeder Second Annual Hidden Gems Conference on October 13, 2008 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) at the Waldorf=Astoria Hotel in New York City....

  Articles 2008-10-07

• Zacks Analyst Blog Highlights: Eli Lilly and Co., Marriott International, Inc., Arena Pharmaceuticals, Inc., ArvinMeritor, Inc. and Echelon Corp

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli Lilly and Co. (NYSE: LLY), Marriott International, Inc. (NYSE: MAR),...

  Articles 2008-10-06

• Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference

  SAN DIEGO, Sept. 17 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the UBS Global Life Sciences Conference on September 23, 2008 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) at the Grand Hyatt Hotel in New York City. Dominic...

  Articles 2008-09-17

• Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights

  SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2008. Total revenues in the second quarter of 2008 were $2.6 million, compared to $4.8 million in the second quarter of 2007, and included $2.0 million...

  Articles 2008-08-05

• Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008

  SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. today announced it will report second quarter 2008 financial results after the NASDAQ Global Market closes on Tuesday, August 5, 2008. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President,...

  Articles 2008-07-29

• Comprehensive Evaluation of Pharmaceutical Wholesalers and Distributors in the UK

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/249b33/pharmaceutical_who) has announced the addition of the "Pharmaceutical Wholesalers & Distributors UK - Portfolio Analysis" report to their offering. The Plimsoll Portfolio Analysis - Pharmaceutical Wholesalers & Distributors is a comprehensive evaluation of the UK market. The revised and...

  Articles 2008-07-02

• Now In Its Fourth Year, 'The CNS Market 2008 Report' Is an Expanded and Updated 400 Page Report of Brain and Nervous System Markets and Treatments

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/ab0827/the_cns_market_200) has announced the addition of the "The CNS Market 2008 Report" published by NeuroInsights to their offering. Drugs, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease...

  Articles 2008-06-12

• Obesity market set for huge growth

  THE MARKET FOR obesity treatments will grow five-fold by 2016, according to research firm Decision Resources. The category, worth an estimated $478 million in 2006, will grow to $2.7 billion by 2016 in the US, UK, France, Germany, Italy, Spain and Japan, the firm projected. Growth will be...

  Articles 2008-06-01

• Robert Hoffman

  [ILLUSTRATION OMITTED] Robert E. Hoffman has served as Arena Pharmaceuticals' vice president, finance, since April 2000 and CFO since December 2005. Since 1997 he's also served as Arena's controller and chief accounting officer. Hoffman has been instrumental in Arena's fund-raising activities, and has helped raise nearly $1billion during...

  Articles 2008-05-19

• New Analyst Reports for REAL GOODS SOLAR INC, HOLOGIC INC, ARENA PHARMACEUTICALS INC, and BIOCRYST PHARMACEUTICALS INC

  MaybachFinancial.com is one of the fastest growingindependent and unbiased research firms in the world. Through our numerouspartnerships with many of the top investment minds in the world, we provideresearch on companies making a move in the markets. Investors seekinggenuine analyst opinions on their investments for REAL GOODS SOLAR INC(NASDAQ: RSOL),...

  Articles 2008-05-08

• Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference

  SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the Bank of America 2008 Healthcare Conference on May 14, 2008 at 5:20 p.m. Pacific Time (8:20 p.m. Eastern Time) at the Four Seasons Hotel in Las Vegas, Nevada....

  Articles 2008-05-08

• Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd

  SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. announced today that Taisho Pharmaceutical Co., Ltd. initiated a Phase 1 clinical trial of a drug candidate under a GPCR-focused partnership with Arena to develop compounds to treat psychiatric disorders. The drug candidate is a novel oral compound intended...

  Articles 2008-05-07

• Arena Pharmaceuticals Announces First Quarter 2008 Financial Results

  SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2008. Total revenues in the first quarter of 2008 were $2.6 million, compared to $4.9 million in the first quarter of 2007, and included $2.0 million...

  Articles 2008-05-07

• Arena Pharmaceuticals Inc. Review in Progress.

  M2 PRESSWIRE-17 March 2008-The Maybach Review: Arena Pharmaceuticals Inc. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:17032008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about...

  Articles 2008-03-17

• Arena Pharmaceuticals' Lorcaserin for Obesity Passes Major Safety Milestone

  - Month-12 Independent Echocardiographic Data Safety Monitoring Board Review Strengthens Lorcaserin's Emerging Cardiovascular Safety Profile - SAN DIEGO, March 17 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. announced today that following a planned review by an independent Echocardiographic Data Safety Monitoring Board EDSMB it is continuing BLOOM (Behavioral...

  Articles 2008-03-17

• Global Market Review for Arena Pharmaceuticals, Inc.

  M2 PRESSWIRE-17 March 2008-The SI Report: Global Market Review for Arena Pharmaceuticals, Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:17032008 Streetinvesting.com has now resumed our progressive review of Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) after it traded down less than 1% Monday, early...

  Articles 2008-03-17